My PCR
Create Account
Logo PCR

15 May 2024

Renal denervation

The turning point in hypertension care: Symplicity Spyral renal denervation in practice

Sponsored by Medtronic

Anchorperson: F. Ribichini
Spokesperson: R. Al-Lamee
SHOW MORE

Summary

Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety guidelines, and setting up effective renal denervation programs in collaboration with referring physicians.

Learning Objectives

  • To know the upgraded recommendation of renal denervation for hypertension treatment in the latest guidelines
  • To understand how to perform a safe and effective renal denervation procedure
  • To learn how to set up a renal denervation programme and partner with referring physicians on patient selection
Related Content
Share your work at PCR-CIT China Chengdu Valves 2025 GulfPCR-GIM 2025: Call for Submissions is open New frontier in renal denervation: data, devices and developments
Recommended for you
AICT-AsiaPCR: what's in store this year? AICT-AsiaPCR: Call for Submissions is now open A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension